A study for a 51 year old woman who takes Luvox, Wellbutrin - from FDA reports

36 females aged 51 (±5) who take the same drugs are studied. This is a personalized study for a 51 year old female patient who has Anxiety, Depression. The study is created by eHealthMe based on reports from FDA.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).

On Aug, 18, 2018

36 females aged 51 (±5) who take Luvox, Wellbutrin are studied.

Number of reports submitted per year:

Luvox, Wellbutrin for a 51-year old woman.

Information of the patient in this study:

  • Age: 51
  • Gender: female
  • Conditions: Anxiety, Depression
  • Drugs taken:
    • Luvox (fluvoxamine maleate)
    • Wellbutrin (bupropion hydrochloride)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
  1. Fainting (loss of consciousness and postural tone)
  2. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Loss of consciousness
  5. Tongue biting
1 - 6 months:
  1. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
6 - 12 months:
  1. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
1 - 2 years:
2 - 5 years:
5 - 10 years:
10+ years:
not specified:
  1. High blood cholesterol
  2. Tongue disorder (disease of tongue)
  3. Head injury
  4. Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
  5. Memory loss

Top conditions involved for these people *:

  1. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 6 people, 16.67%
  2. Menopause (end of monthly cycles in women): 6 people, 16.67%
  3. Sleep Disorder : 6 people, 16.67%
  4. Pain : 6 people, 16.67%
  5. Hormone Replacement Therapy : 6 people, 16.67%

Top co-used drugs for these people *:

  1. Remeron (10 people, 27.78%)
  2. Zoloft (9 people, 25.00%)
  3. Lexapro (8 people, 22.22%)
  4. Evista (7 people, 19.44%)
  5. Prevacid (7 people, 19.44%)

* Some reports may have incomplete information.

FDA reports used in this study

You are not alone:

What are the drugs?

What are the conditions?

Related studies:

Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.